Differential action of spasmolytic vasodilators on platelet aggregation and endothelial cell-dependent anti-aggregation

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 4, 2000, Pages 417-422

  Az Ma, T ^a,b   Saeki, N ^a   Yuge, O ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Hiroshima Red Cross/Atom Bomb S H ^*  (Japan)

Author keywords

Endothelial cells; Papaverine; Pentobarbital; Platelet aggregation; Prostaglandin E1; Spasmolytic Vasodilators

Indexed keywords

BRADYKININ; COLLAGEN; DILTIAZEM; GLYCERYL TRINITRATE; NICARDIPINE; NITROPRUSSIDE SODIUM; PAPAVERINE; PENTOBARBITAL; PROSTAGLANDIN E1; SPASMOLYTIC AGENT; VASODILATOR AGENT;

ANIMAL CELL; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; VASCULAR ENDOTHELIUM; VASOSPASM;

ALPROSTADIL; ANIMALS; AORTA; CELLS, CULTURED; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; NICARDIPINE; NITROGLYCERIN; NITROPRUSSIDE; PAPAVERINE; PENTOBARBITAL; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SWINE; SYMPATHOLYTICS; VASODILATOR AGENTS;

EID: 0034015389     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.440410.x     Document Type: Article

References (33)

1. 1. Geter RK, Winters RRW, Pucket CL. Resolution of experimental microvascular spasm and improvement in anastomotic patency by direct topical agent application. Plast Reconstr Surg 1986: 77: 105-115.
2. 2. Seaber AV. Experimental vasospasm. Microsurgery 1987: 8: 234-241.
3. 3. Beekman WH, Sluimers JE, Kort WJ, Van-der-Meulen JC. Resolution of experimental microvascular vasoconstriction in rats by topical application of lidocaine hydrochloride in varying concentrations. Ann Plast Surg 1988: 21: 570-575.
4. 4. Beekman WH, Dammeijer PF, Sluimers JE, Kort WJ, Vander-Meulen JH. Improvement in blood flow and diameter of the postanastomotic rat tail artery by topical application of lidocaine in varying concentrations. Ann Plast Surg 1990: 24: 248-251.
5. 5. Wadstrom J, Gerdin B. Modulatory effects of topically administered lidocaine and pentobarbital on traumatic vasospasm in the rabbit ear artery. Br J Plast Surg 1991: 44: 341-347.
6. 6. Arner M, Hogestatt ED. Actions of some vasodilators on isolated human hand veins. Acta Physiol Scand 1987: 130: 671-677.
7. 1 on microcirculation of rat cremaster muscle. Microsurgery 1990: 11: 204-208.
8. 8. Watts JA, Hawes EM, Jenkins SH, Williams TC. Effects of nisoldipine on the no-reflow phenomenon in globally ischemic rat hearts. J Cardiovasc Pharmacol 1990: 16: 487-494.
9. 9. Sassen LM, Bezstarosti K, Verdouw PD, Lamers JM. Effects of nisoldipine on recovery of coronary blood flow, sarcoplasmic reticulum function and other biochemical parameters in post-ischaemic porcine myocardium. Biochem Pharmacol 1991: 41: 43-51.
10. 10. Villari B, Ambrosio G, Golino P, Ragni M, Focaccio A, Tritto I et al. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the noreflow phenomenon in reperfused hearts. Am Heart J 1993: 125: 11-23.
11. 11. Kim-Lee MH, Stokes BT, McDonald JS. Procaine, lidocaine, and hypothermia inhibit calcium paradox in glial cells. Anesth Analg 1994: 79: 728-733.
12. 12. Rousseau G, Provost P, Tran D, Caille G, Latour JG. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog. J Pharmacol Exp Ther 1994: 268: 1252-1260.
13. 13. Kamiyama T, Tanonaka K, Harada H, Nakai K, Takeo S. Mexiletine and lidocaine reduce post-ischemic functional and biochemical dysfunction of perfused hearts. Eur J Pharmacol 1995: 272: 151-158.
14. 14. Massoudy P, Becker BF, Seligmann C, Gerlach E. Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart. Cardiovasc Res 1995: 29: 577-582.
15. 15. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987: 92: 181-187.
16. 16. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregation properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmcol 1987: 92: 639-646.
17. 17. Az-ma T, Hardian, Yuge O. Inhibitory effect of lidocaine on cultured porcine aortic endothelial cell dependent anti-aggregation of platelets. Anesthesiology 1995: 83: 374-381.
18. 2+ channels. Br J Pharmacol 1999: 126: 1462-1470.
19. 19. Robertson RM, Robertson D. Drugs used for the treatment of myocardial ischemia. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The pharmacological basis of therapeutics. New York: The McGraw-Hill Companies Inc, 1996: 759-779.
20. 20. Kaneda T, Shimizu K, Nakajyo S, Urakawa N. The difference in the inhibitory mechanisms of papaverine on vascular and intestinal smooth muscles. Eur J Pharmacol 1998: 355: 149-157.
21. 21. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987: 39: 163-196.
22. 22. Campbell WB, Halushka PV. Lipid-derived autacoids. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The pharmacological basis of therapeutics. New York: The McGraw-Hill Companies Inc, 1996: 601-616.
23. 23. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991: 43: 109-142.
24. 24. Adams DJ, Barakeh J, Laskey R, Van-Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989: 3: 2389-2400.
25. 25. Az-ma T, Fujii K, Yuge O. Inhibitory effect of sevoflurane on nitric oxide release from cultured endothelial cells. Eur J Pharmacol 1995: 289: 33-39.
26. 26. Pales J, Palacios-Araus L, Lopes A, Gual A. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets. Biochim Biophys Acta 1991: 1064: 169-174.
27. 27. Yamada Y, Furui H, Furumichi T, Suzuki T, Yamauchi K, Yokota M et al. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation. Jpn Heart J 1989: 31: 201-215.
28. 28. Guyton AC, Hall JE. Contraction and excitation of smooth muscle. In: Textbook of medical physiology. Philadelphia: W. B. Saunders Company, 1996: 95-103.
29. 1 to improve lung preservation. Circ Res 1996: 79: 773-783.
30. 30. Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Wilcox DE. Effects of temperature, oxygen, heme ligands and sulfhydryl alkylation on the reactions of nitroprusside and nitroglycerin with hemoglobin. Biochem Pharmacol 1993: 46: 95-102.
31. 31. Rao DNR, Elguindi S, O'Brien PJ. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch Biochem Biophys 1991: 286: 30-37.
32. 32. Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol 1996: 270: C778-C785.
33. 33. Jernbeck J, Samuelson UE. Effects of lidocaine and calcitonin gene-related peptide (CGRP) on isolated human radial arteries. J Reconstr Microsurg 1993: 9: 361-365.